Event 
Medical 
Corporate 
2020-12-22
Precision medicine enables urothelial carcinoma patient to be treated with targeted therapy for renal cancer
One patient's urothelial carcinoma progressed rapidly while surgery and chemotherapy were ineffective. Two genomic mutations were found through genomic profiling, and targeted therapy for renal cancer was used to control cancer.
Published:
Taipei
Author(s):
2020-09-16
Genomic sequencing helps the combination of two immune checkpoint inhibitors to control stage IV nasopharyngeal carcinoma
A cancer patient is identified by comprehensive genomic profiling as TMB-H with better response to immunotherapy and the combination of two immune checkpoint inhibitors is used to control stage IV nasopharyngeal carcinoma successfully
Published:
Taipei
Author(s):
2020-08-03
The special disease progress of a 62-year-old lung cancer patient is controlled after performing genomic profiling sequencing twice
The treatment options for late-stage lung cancer treatment are limited and NGS can overcome brain metastases mostly seen in late-stage.
Published:
Taipei
Author(s):
2020-07-27
Genomic profiling can find right drug for late-stage ovarian cancer patients
Cancer genomic profiling is the key to prevent recurrence of late-stage ovarian cancer. Sequencing 48 DNA repair genes at once can find right targeted drugs to extend the PFS of ovarian cancer patients.
Published:
Taipei
Author(s):
2020-06-16
ACT Genomics is the first one to receive Taiwan LDTS
Laboratory Developed Tests and Services, LDTS is the new tread which affecting out quality of medical treatment, and ACT Genomics is the first one to receive Taiwan LDTS. Let's see how ACT Genomics reaches hits high-quality control.
Published:
Taipei
Author(s):
2020-03-18
Reverse treatment process for late-stage lung cancer to increase success rate
If there is genetic information for late stage lung cancer when diagnosed, the success rate for patients' treatment strategy will be higher.
Published:
Taipei
Author(s):
2020-02-11
Find solutions for unique genetic mutations, precision medicine brings new hope for cancer treatment
Cancer patients use precision medicine-guided treatment can have better outcome than traditional treatment；patients who carry unique genetic mutations such as NTRK fusion genes can have better response rate using NTRK inhibitor.
Published:
Taipei
Author(s):
2019-11-28
Avoid ineffective cancer treatments Precision Medicine increase treatment effectiveness
Precision Medicine can improve uncertainty of treatment results due to genetic alterations and receive better treatment
Published:
Taipei
Author(s):
2019-11-06
cancer genomic profiling empowers gynecologic oncologists to fight against late-stage ovarian caner
Choosing appropriate cancer drugs via comprehensive cancer genomic profiling can help young ovarian cancer patients to survive longer and preserve fertility.
Published:
Taipei
Author(s):
2019-09-09
Immunotherapy empower an 87- year- old patient to defeat skin cancer relapse
An 87-year-old patient suffered from skin cancer relapse , ACTOnco+ helped her understood cancer genetic mutations and she was lucky to be the 20% who can benefit from immunotherapy
Published:
Yun-lin
Author(s):
